To explore the application of cells expanded from plucked hair follicles after collection, transport, and cryopreservation, in disease modeling and cell-based therapies.

Hair Follicles collected and transported in Acorn's proprietary transport media can serve has therapeutic starting materials for future cell-based therapeutics. This study is to characterize primary cell outgrowth, functional stem cell generation and induced pluripotent stem cell line(s) from primary outgrowth(s) as well as evaluate and characterize differentiation of stem cell lines into functional cell types required for various disease states and cell-based application(s).

Inclusion Criteria:

• Gender: Male or Female.
• Age: ≥18 and ≤80 years.
• Language proficiency: Able to read and understand English.
• Informed consent: Willing to provide written, informed consent to participate in all study activities.

Exclusion Criteria:

• Scalp/Hair Disorders: Subjects diagnosed with active scalp infections or inflammatory skin conditions.
• Systemic Conditions: Subjects with chronic illnesses, such as autoimmune diseases or diabetes, that may impact scalp health or wound healing.
• Medications: Subjects on immunosuppressants, steroids, or other medications associated with hair loss.

Healthy population, aged 18-80, without scalp or hair disorders, chronic illnesses that may impact scalp health or wound healing, and not on immunosuppressants, steroids, or medications that cause hair loss.